Since BCR-ABL fusion can occur in myeloid, B lymphoid, erythroid and sporadically T lymphoid cells in the majority of CML patients, the consensus is that the original translocation takes place in LT-HSCs (Fialkow et al., 1977). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.